Sanofi India Limited, a prominent player in the Indian pharmaceutical sector, was initially incorporated as Aventis Pharma Limited in 1956, and rebranded in 2012. As a leading multinational company, it focuses on manufacturing and trading pharmaceuticals, with facilities in Goa and Ankleshwar, Gujarat. Notable products include Lantus, Combiflam, Amaryl, and Allegra, recognized among India's top pharmaceutical brands. Sanofi and its subsidiary Hoechst GmbH collectively own a 60.37% stake in the company.
Sanofi India has engaged in strategic initiatives, such as acquiring Universal Medicare’s nutraceutical business in 2011 and launching various innovative products like the AllStar insulin pen and Combiflam Plus. It has also streamlined its operations by selling commercial properties and divesting its nutraceuticals business in 2021. The company continues to expand its product portfolio with recent launches in neurology and cardiology, while its consumer healthcare segment was demerged into a separate entity in 2022-23.
